Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Removal of dental amalgam decreases anti-TPO and anti-Tg autoantibodies in patients with autoimmune thyroiditis *

OBJECTIVES: The impact of dental amalgam removal on the levels of anti- thyroid
peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) antibodies was studied in
patients with autoimmune thyroiditis (AT) with and without mercury allergy.
METHODS: Thirty-nine patients with AT were tested by an optimized lymphocyte
proliferation test, MELISA® for allergy (hypersensitivity) to inorganic mercury.
Patients were divided into two groups: Group I (n = 12) with no hypersensitivity
to mercury and Group II (n = 27) with hypersensitivity to mercury. Amalgam
fillings were removed from the oral cavities of 15 patients with hyperensitivity
to mercury (Group IIA) and left in place in the remaining 12 patients (Group
IIB). The laboratory markers of AT, anti-TPO and anti-Tg autoantibodies were
determined in all groups at the beginning of the study and six months later.
RESULTS: Compared to levels at the beginning of the study, only patients with
mercury hypersensitivity who underwent amalgam replacement (Group IIA)
showed a significant decrease in the levels of both anti-Tg (p=0.001) and anti-TPO
(p=0.0007) autoantibodies. The levels of autoantibodies in patients with or without
mercury hypersensitivity (Group I and Group IIB) who did not replace amalgam
did not change.
CONCLUSION: Removal of mercury-containing dental amalgam in patients with
mercury hypersensitivity may contribute to successful treatment of autoimmune

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 11-20-2009
Authors: Ivan Sterzl, Jarmila Prochazkova, Pavlina Hrda, Petr Matucha, Jirina Bartova & Vera D.M. Stejskal
Source: Neuroendocrinol Lett 2006; 27(Suppl 1),:101-000